Management of Klebsiella pneumoniae KPC outbreak in internal medicine

Acta Medica Mediterranea

Volumn 32, Issue 3, 2016, Pages 823-827

  Bellodi, Andrea ^a   Del Corso, Lisette ^a   Favorini, Serena ^a   Molinari, Elisa ^a   Coppo, Erika ^a   Orengo, Giovanni ^a   Del Bono, Valerio ^a   Ghio, Riccardo ^a   Arboscello, Eleonora ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antibiotic resistance; Carbapenemase; Infection control; Internal medicine; Klebsiella pneumoniae KPC; Outbreak

Indexed keywords

AMIKACIN; CARBAPENEM DERIVATIVE; COLISTIN; FOSFOMYCIN; GENTAMICIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; TIGECYCLINE; VANCOMYCIN;

ABDOMINAL DRAINAGE; ADULT; AGED; ARTICLE; BLOOD CULTURE; BLOODSTREAM INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; DRUG MEGADOSE; EPIDEMIC; FEMALE; HUMAN; INFECTION RISK; ITALY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; KLEBSIELLA PNEUMONIAE PRODUCING CARBAPENEMASE; LUNG LAVAGE; MALE; MORTALITY; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; SPUTUM CULTURE; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT; URINARY CATHETER; URINARY TRACT INFECTION; URINE CULTURE; WOUND;

EID: 84994338135     PISSN: 03936384     EISSN: None     Source Type: Journal    
DOI: 10.19193/0393-6384_2016_3_97     Document Type: Article

References (14)

1. Yigit H, Queenan AM, Anderson JG, Domenech-Sanchez A, Biddle JW, et al. Novel carbapenemhydrolyzing beta lactamase KPC-1 from a resistant strain of Klebsiella Pneumoniae. Antimicrob agents chemother 2001; 45: 1151-61.
2. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella Pneumoniae carbapenemase producing bacteria. Lancet Infect Dis 2009 apr; 45(4): 228-36.
3. Arnold RS, Thom KA, Sharma S, Phillips M, Kristie Johnson J, Morgan DJ. Emergence of Klebsiella pneumoniae carbapenemase producing bacteria. South Med J 2011 Jan; 104(1): 40-5.
4. Giani T, D'Andrea MM, Pecile P, Borgianni L, Nicoletti P, et al. Emergency in Italy of Klebsiella Pneumoniae sequence type 258 producing KPC-3 carbapenemase. J Clin Microbiol 2009; 47: 3793-4.
5. Endimiani A, Depasquale JM, Forero S, Perez F, Hujer AM, et al. Emergency of blakpc-containg Klebsiella Pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J antimicrob chemother 2009; 64: 1102-10.
6. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints. EUCAST. [Accessed 12 jan 2013]. Available at: http://www.eucast.org/clinical_breakpoints
7. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Informational Supplement. Clinical and Laboratory Standards Institute CLSI, Wayne, PA (2010). Available at: http://www.clsi.org
8. Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis 2004; 39 (1): 55-60
9. Nowrouzian F, Hesselmar B, Saalman R, Strannegard IL, Aberg N, et al. Escherichia coli in infants' intestinal microflora: colonization rate, strain turnover, and virulence gene carriage. Pediatr Res 2003; 54: 8-14.
10. Annual epidemiological report: Reporting on 2010 surveillance data and 2011 epidemic intelligence data, European Centre for Disease Prevention and Control. Available at: http://www.ecdc.europa.eu/en/publications/publications/annual-epidemiological-report-2012.pdf
11. Munoz-Price L, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13: 785-96.
12. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012; Oct; 55(7): 943-50.
13. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chmother 2010 Jun; 65(6): 1119-25.
14. Zuckerman T, Benyamini N, Sprecher H, Fineman R, Finkelstein R, et al. SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state. Bone Marrow Transplant 2011 Sep; 46(9): 1226-30.